Literature DB >> 26688531

Increased risk of latent tuberculous infection among persons with pre-diabetes and diabetes mellitus.

R L Hensel1, R R Kempker2, J Tapia3, A Oladele4, H M Blumberg5, M J Magee6.   

Abstract

SETTING: Although diabetes mellitus (DM) is an established risk factor for active tuberculosis (TB) disease, little is known about the association between pre-DM, DM, and latent tuberculous infection (LTBI).
OBJECTIVE: To estimate the association between DM and LTBI.
DESIGN: We conducted a cross-sectional study among recently arrived refugees seen at a health clinic in Atlanta, GA, USA, between 2013 and 2014. Patients were screened for DM using glycosylated-hemoglobin (HbA1c), and for LTBI using the QuantiFERON(®)-TB (QFT) test. HbA1c and QFT results, demographic information, and medical history were abstracted from patient charts.
RESULTS: Among 702 included patients, 681 (97.0%) had HbA1c and QFT results. Overall, 54 (7.8%) patients had DM and 235 (33.8%) had pre-DM. LTBI was prevalent in 31.3% of the refugees. LTBI prevalence was significantly higher (P < 0.01) among patients with DM (43.4%) and pre-DM (39.1%) than in those without DM (25.9%). Refugees with DM (adjusted OR [aOR] 2.3, 95%CI 1.2-4.5) and pre-DM (aOR 1.7, 95%CI 1.1-2.4) were more likely to have LTBI than those without DM.
CONCLUSION: Refugees with DM or pre-DM from high TB burden countries were more likely to have LTBI than those without DM. Dysglycemia may impair the immune defenses involved in preventing Mycobacterium tuberculosis infection.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26688531      PMCID: PMC5652325          DOI: 10.5588/ijtld.15.0457

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN: 1027-3719            Impact factor:   2.373


  23 in total

1.  Effect of diabetes on tuberculosis control in 13 countries with high tuberculosis: a modelling study.

Authors:  Sung-Ching Pan; Chu-Chang Ku; Diana Kao; Majid Ezzati; Chi-Tai Fang; Hsien-Ho Lin
Journal:  Lancet Diabetes Endocrinol       Date:  2015-03-06       Impact factor: 32.069

2.  Interferon-γ release assays for the evaluation of tuberculosis infection.

Authors:  Henry M Blumberg; Russell R Kempker
Journal:  JAMA       Date:  2014-10-08       Impact factor: 56.272

3.  Hypodense alveolar macrophages in patients with diabetes mellitus and active pulmonary tuberculosis.

Authors:  C H Wang; C T Yu; H C Lin; C Y Liu; H P Kuo
Journal:  Tuber Lung Dis       Date:  1999

4.  Kinetics and cellular sources of cathelicidin during the course of experimental latent tuberculous infection and progressive pulmonary tuberculosis.

Authors:  J Castañeda-Delgado; R Hernández-Pando; C J Serrano; D Aguilar-León; J León-Contreras; C Rivas-Santiago; R Méndez; I González-Curiel; A Enciso-Moreno; B Rivas-Santiago
Journal:  Clin Exp Immunol       Date:  2010-09       Impact factor: 4.330

Review 5.  Circulating 25-hydroxyvitamin D concentration and the risk of type 2 diabetes: results from the European Prospective Investigation into Cancer (EPIC)-Norfolk cohort and updated meta-analysis of prospective studies.

Authors:  N G Forouhi; Z Ye; A P Rickard; K T Khaw; R Luben; C Langenberg; N J Wareham
Journal:  Diabetologia       Date:  2012-04-15       Impact factor: 10.122

6.  Diabetic control and risk of tuberculosis: a cohort study.

Authors:  Chi C Leung; Tai H Lam; Wai M Chan; Wing W Yew; Kin S Ho; Gabriel M Leung; Wing S Law; Cheuk M Tam; Chi K Chan; Kwok C Chang
Journal:  Am J Epidemiol       Date:  2008-04-08       Impact factor: 4.897

7.  Non-diabetic hyperglycemia exacerbates disease severity in Mycobacterium tuberculosis infected guinea pigs.

Authors:  Brendan K Podell; David F Ackart; Natalie M Kirk; Sarah P Eck; Christopher Bell; Randall J Basaraba
Journal:  PLoS One       Date:  2012-10-04       Impact factor: 3.240

8.  Vitamin d deficiency and tuberculosis progression.

Authors:  Najeeha Talat; Sharon Perry; Julie Parsonnet; Ghaffa Dawood; Rabia Hussain
Journal:  Emerg Infect Dis       Date:  2010-05       Impact factor: 6.883

Review 9.  Diabetes mellitus increases the risk of active tuberculosis: a systematic review of 13 observational studies.

Authors:  Christie Y Jeon; Megan B Murray
Journal:  PLoS Med       Date:  2008-07-15       Impact factor: 11.069

Review 10.  Improving tuberculosis prevention and care through addressing the global diabetes epidemic: from evidence to policy and practice.

Authors:  Knut Lönnroth; Gojka Roglic; Anthony D Harries
Journal:  Lancet Diabetes Endocrinol       Date:  2014-09       Impact factor: 32.069

View more
  25 in total

Review 1.  Diabetes and Tuberculosis.

Authors:  Blanca I Restrepo
Journal:  Microbiol Spectr       Date:  2016-12

Review 2.  Stress Hyperglycemia in Patients with Tuberculosis Disease: Epidemiology and Clinical Implications.

Authors:  Matthew J Magee; Argita D Salindri; Nang Thu Thu Kyaw; Sara C Auld; J Sonya Haw; Guillermo E Umpierrez
Journal:  Curr Diab Rep       Date:  2018-08-09       Impact factor: 4.810

3.  Changes in tuberculosis epidemiology, United States, 1993-2017.

Authors:  L R Armstrong; C A Winston; B Stewart; C A Tsang; A J Langer; T R Navin
Journal:  Int J Tuberc Lung Dis       Date:  2019-07-01       Impact factor: 2.373

Review 4.  Defining a Research Agenda to Address the Converging Epidemics of Tuberculosis and Diabetes: Part 1: Epidemiology and Clinical Management.

Authors:  Julia A Critchley; Blanca I Restrepo; Katharina Ronacher; Anil Kapur; Andrew A Bremer; Larry S Schlesinger; Randall Basaraba; Hardy Kornfeld; Reinout van Crevel
Journal:  Chest       Date:  2017-04-20       Impact factor: 9.410

Review 5.  Convergence of non-communicable diseases and tuberculosis: a two-way street?

Authors:  M J Magee; A D Salindri; U P Gujral; S C Auld; J Bao; J S Haw; H-H Lin; H Kornfeld
Journal:  Int J Tuberc Lung Dis       Date:  2018-11-01       Impact factor: 2.373

6.  Impacts of metformin on tuberculosis incidence and clinical outcomes in patients with diabetes: a systematic review and meta-analysis.

Authors:  Meng Zhang; Jian-Qing He
Journal:  Eur J Clin Pharmacol       Date:  2019-11-30       Impact factor: 2.953

7.  BCG vaccination reduces the mortality of Mycobacterium tuberculosis-infected type 2 diabetes mellitus mice.

Authors:  Rajesh Kumar Radhakrishnan; Ramya Sivangala Thandi; Deepak Tripathi; Padmaja Paidipally; Madeline Kay McAllister; Sachin Mulik; Buka Samten; Ramakrishna Vankayalapati
Journal:  JCI Insight       Date:  2020-03-12

8.  Glycemic Control and the Prevalence of Tuberculosis Infection: A Population-based Observational Study.

Authors:  Leonardo Martinez; Limei Zhu; Maria E Castellanos; Qiao Liu; Cheng Chen; Benjamin D Hallowell; Christopher C Whalen
Journal:  Clin Infect Dis       Date:  2017-11-29       Impact factor: 9.079

9.  Latent tuberculosis infection among patients with and without type-2 diabetes mellitus: results from a hospital case-control study in Atlanta.

Authors:  Argita D Salindri; J Sonya Haw; Genet A Amere; Joyce T Alese; Guillermo E Umpierrez; Matthew J Magee
Journal:  BMC Res Notes       Date:  2021-06-30

10.  The association of glycemic level and prevalence of tuberculosis: a meta-analysis.

Authors:  Zhifei Chen; Qi Liu; Ranran Song; Wenxin Zhang; Tingping Wang; Zhan Lian; Xuezhi Sun; Yanli Liu
Journal:  BMC Endocr Disord       Date:  2021-06-16       Impact factor: 2.763

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.